Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerWillemien J. van Driel, Gabe S. Sonke, Henriëtte J.G. Arts et al.|New England Journal of Medicine|2018Cited by 1.4k
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialJan B. Vermorken, Herbert M. Pinedo, A.M.E. Claessen et al.|The Lancet|1999Cited by 503
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)Jolien M. Bueno-de-Mesquita, Sabine C. Linn, Wim H. van Harten et al.|The Lancet Oncology|2007Cited by 278
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast CancerSjoerd Rodenhuis, Elisabeth G.E. de Vries, M. Bontenbal et al.|New England Journal of Medicine|2003Cited by 262
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancerMarieke E. Straver, Sjoerd Rodenhuis, Annuska M. Glas et al.|Breast Cancer Research and Treatment|2009Cited by 256